IC
NUVB icon

IEQ Capital’s Nuvation Bio NUVB Stock Holding History

IEQ Capital’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1M Sell
233,352
-40,709
-15% -$227K ﹤0.01% 1047
2025
Q4 		$2.46M Sell
274,061
-24,306
-8% -$151K 0.01% 724
2025
Q3 		$1.1M Buy
298,367
+181,185
+155% +$494K ﹤0.01% 972
2025
Q2 		$229K Buy
117,182
+89,767
+327% +$187K ﹤0.01% 1544
2025
Q1 		$48.3K Sell
27,415
-9,578
-26% -$21.8K ﹤0.01% 1550
2024
Q4 		$98.4K Buy
+36,993
New +$95.2K ﹤0.01% 1268

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

IEQ Capital's NUVB Position: Q1 2026 in Review

IEQ Capital reduced its Nuvation Bio (NUVB) stake by 15% in Q1 2026, selling an estimated $227K and leaving 233,352 shares worth $1M. The position accounts for ﹤0.01% of the portfolio, ranked #1047.

IEQ Capital first reported a position in NUVB in Q4 2024 and has held it in 6 quarters since. The position peaked at $2.46M in Q4 2025. 231 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.

  • IEQ Capital held 233,352 shares of Nuvation Bio worth $1M as of Q1 2026.
  • IEQ Capital sold 40,709 Nuvation Bio shares in Q1 2026, an estimated $227K.
  • Nuvation Bio made up ﹤0.01% of IEQ Capital's portfolio in Q1 2026, its #1047 holding.
  • IEQ Capital first reported a position in Nuvation Bio in Q4 2024 and has held it in 6 quarters since.
  • IEQ Capital's Nuvation Bio position peaked at $2.46M in Q4 2025.
  • 231 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.

Based on IEQ Capital's 13F filing for Q1 2026, filed 15 May 2026.